The O subfamily of forkhead (FoxO) 1 is a crucial regulator of cell metabolism in several tissues, including the heart, where it is involved in cardiac regulation of glucose and lipid metabolic pathways, and endothelium, controlling the levels of some relevant biomarkers in atherosclerotic process. Despite the growing understanding of FoxO1 biology, the metabolic consequences of FoxO1 modifications and its implication in CVD, atherosclerosis and T2DM are still not incompletely described. In this review we discuss how FoxO1 affects cardiovascular pathophysiology and which of its effects should be restrained or enhanced to preserve endothelial and heart functions.

Menghini, R., Casagrande, V., Iuliani, G., Rizza, S., Mavilio, M., Cardellini, M., et al. (2020). Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?. THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 118, 105659 [10.1016/j.biocel.2019.105659].

Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?

Menghini R.;Casagrande V.;Iuliani G.;Rizza S.;Mavilio M.;Cardellini M.;Federici M.
2020-01-01

Abstract

The O subfamily of forkhead (FoxO) 1 is a crucial regulator of cell metabolism in several tissues, including the heart, where it is involved in cardiac regulation of glucose and lipid metabolic pathways, and endothelium, controlling the levels of some relevant biomarkers in atherosclerotic process. Despite the growing understanding of FoxO1 biology, the metabolic consequences of FoxO1 modifications and its implication in CVD, atherosclerosis and T2DM are still not incompletely described. In this review we discuss how FoxO1 affects cardiovascular pathophysiology and which of its effects should be restrained or enhanced to preserve endothelial and heart functions.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/09
English
FoxO1
Type 2 diabetes
Atherosclerosis
Cardiovascular Diseases
Menghini, R., Casagrande, V., Iuliani, G., Rizza, S., Mavilio, M., Cardellini, M., et al. (2020). Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?. THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 118, 105659 [10.1016/j.biocel.2019.105659].
Menghini, R; Casagrande, V; Iuliani, G; Rizza, S; Mavilio, M; Cardellini, M; Federici, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Foxo review 2020.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 311.57 kB
Formato Adobe PDF
311.57 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/297161
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 14
social impact